SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Mazo I)
 

Sökning: WFRF:(Mazo I) > (2020) > Efficacy, cost-util...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00008401naa a2200673 4500
001oai:DiVA.org:uu-459895
003SwePub
008211206s2020 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4598952 URI
024a https://doi.org/10.1136/bmjopen-2020-0381072 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Sanabria-Mazo, Juan P.u Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.;Univ Int Catalunya, Dept Med, Barcelona, Spain.;Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
2451 0a Efficacy, cost-utility and physiological effects of Acceptance and Commitment Therapy (ACT) and Behavioural Activation Treatment for Depression (BATD) in patients with chronic low back pain and depression :b study protocol of a randomised, controlled trial including mobile-technology-based ecological momentary assessment (IMPACT study)
264 c 2020-07-23
264 1b BMJ,c 2020
338 a electronic2 rdacarrier
520 a Introduction The IMPACT study focuses on chronic low back pain (CLBP) and depression symptoms, a prevalent and complex problem that represents a challenge for health professionals. Acceptance and Commitment Therapy (ACT) and Brief Behavioural Activation Treatment for Depression (BATD) are effective treatments for patients with persistent pain and depression, respectively. The objectives of this 12 month, multicentre, randomised, controlled trial (RCT) are (i) to examine the efficacy and cost-utility of adding a group-based form of ACT or BATD to treatment-as-usual (TAU) for patients with CLBP and moderate to severe levels of depressive symptoms; (ii) identify pre-post differences in levels of some physiological variables and (iii) analyse the role of polymorphisms in theFKBP5gene, psychological process measures and physiological variables as mediators or moderators of long-term clinical changes. Methods and analysis Participants will be 225 patients with CLBP and moderate to severe depression symptoms recruited at Parc Sanitari Sant Joan de Deu (St. Boi de Llobregat, Spain) and Hospital del Mar (Barcelona, Spain), randomly allocated to one of the three study arms: TAU vs TAU+ACT versus TAU+BATD. A comprehensive assessment to collect clinical variables and costs will be conducted pretreatment, post-treatment and at 12 months follow-up, being pain interference the primary outcome measure. The following physiological variables will be considered at pretreatment and post-treatment assessments in 50% of the sample: immune-inflammatory markers, hair cortisol and cortisone, serum cortisol, corticosteroid-binding globulin and vitamin D. Polymorphisms in theFKBP5gene (rs3800373, rs9296158, rs1360780, rs9470080 and rs4713916) will be analysed at baseline assessment. Moreover, we will include mobile-technology-based ecological momentary assessment, through the Pain Monitor app, to track ongoing clinical status during ACT and BATD treatments. Linear mixed-effects models using restricted maximum likelihood, and a full economic evaluation applying bootstrapping techniques, acceptability curves and sensitivity analyses will be computed. Ethics and dissemination This study has been approved by the Ethics Committee of the Fundacio Sant Joan de Deu and Hospital del Mar. The results will be actively disseminated through peer-reviewed journals, conference presentations, social media and various community engagement activities.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Allmänmedicin0 (SwePub)302242 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex General Practice0 (SwePub)302242 hsv//eng
650 7a SAMHÄLLSVETENSKAPx Psykologix Tillämpad psykologi0 (SwePub)501022 hsv//swe
650 7a SOCIAL SCIENCESx Psychologyx Applied Psychology0 (SwePub)501022 hsv//eng
653 a pain management
653 a Clinical trials
653 a Depression & mood disorders
700a Forero, Carlos G.u Univ Int Catalunya, Dept Med, Barcelona, Spain.4 aut
700a Cristobal-Narvaez, Paulau Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.;Inst Hlth Carlos III, Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain.4 aut
700a Suso-Ribera, Carlosu Univ Jaume 1, Dept Basic & Clin Psychol & Psychobiol, Castellon de La Plana, Spain.;Inst Hlth Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain.4 aut
700a Garcia-Palacios, Azucenau Univ Jaume 1, Dept Basic & Clin Psychol & Psychobiol, Castellon de La Plana, Spain.;Inst Hlth Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain.4 aut
700a Colomer-Carbonell, Ariadnau Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.;Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
700a Perez-Aranda, Adrianu Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.;Consorci Parc Salut MAR Barcelona, Barcelona, Catalunya, Spain.4 aut
700a Andres-Rodriguez, Laurau Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.4 aut
700a McCracken, Lance M.,d 1962-u Uppsala universitet,Institutionen för psykologi4 aut0 (Swepub:uu)lanmc300
700a D'Amico, Francescou London Sch Econ & Polit Sci, Personal Social Serv Res Unit, London, England.4 aut
700a Estivill-Rodriguez, Pereu Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
700a Carreras-Marcos, Bernatu Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
700a Montes-Perez, Antoniou Consorci Parc Salut MAR Barcelona, Barcelona, Catalunya, Spain.4 aut
700a Comps-Vicente, Olgau Consorci Parc Salut MAR Barcelona, Barcelona, Catalunya, Spain.4 aut
700a Esteve, Montserratu Inst Hlth Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain.;Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain.;Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain.4 aut
700a Grasa, Maru Inst Hlth Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain.;Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain.;Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain.4 aut
700a Rosa, Araceliu Inst Hlth Carlos III, Network Ctr Biomed Res Mental Hlth CIBERSAM, Madrid, Spain.;Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.4 aut
700a Cuesta-Vargas, Antonio, Iu Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia.;Univ Malaga, Dept Physiotherapy, Malaga, Spain.;Biomed Res Inst Malaga IBIMA, Malaga, Spain.4 aut
700a Maes, Michaelu Chulalongkorn Univ, Dept Psychiat, Bangkok, Thailand.4 aut
700a Borras, Xavieru Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.4 aut
700a Edo, Silviau Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.4 aut
700a Sanz, Antoniu Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.4 aut
700a Feliu-Soler, Albertu Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.;Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
700a Castano-Asins, Juan R.u Consorci Parc Salut MAR Barcelona, Barcelona, Catalunya, Spain.4 aut
700a Luciano, Juan, Vu Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.4 aut
710a Autonomous Univ Barcelona, Dept Basic Dev & Educ Psychol, Barcelona, Spain.;Univ Int Catalunya, Dept Med, Barcelona, Spain.;Parc Sanitari St Joan de Deu, St Boi De Llobregat, Catalunya, Spain.b Univ Int Catalunya, Dept Med, Barcelona, Spain.4 org
773t BMJ Opend : BMJg 10:7q 10:7x 2044-6055
856u https://doi.org/10.1136/bmjopen-2020-038107y Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1617419/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://bmjopen.bmj.com/content/bmjopen/10/7/e038107.full.pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-459895
8564 8u https://doi.org/10.1136/bmjopen-2020-038107

Hitta via bibliotek

  • BMJ Open (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy